Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov;16(11):452.
doi: 10.1007/s11883-014-0452-y.

8-hydroxy-2'-deoxyguanosine and cardiovascular disease: a systematic review

Affiliations

8-hydroxy-2'-deoxyguanosine and cardiovascular disease: a systematic review

Lona J Kroese et al. Curr Atheroscler Rep. 2014 Nov.

Abstract

Oxidative stress due to an excess of reactive oxygen species (ROS) may play a role in the development and progression of cardiovascular disease (CVD). 8-hydroxy-2'-deoxyguanosine (8-OHdG) is a marker of oxidative DNA damage caused by ROS. This review aimed to assess the association between 8-OHdG and CVD by reviewing the literature. Studies in human subjects using either plasma or urine to determine 8-OHdG concentrations were surveyed. Eighteen relevant studies were found, of which 13 were case-control studies and five had a prospective design. Without exception, the case-control studies showed significant positive associations between 8-OHdG and CVD. In agreement, two prospective studies showed a significant association of 8-OHdG and heart failure. Furthermore, two prospective studies found a significant association between 8-OHdG and stroke, and finally, one prospective study showed a borderline significant (p = 0.08) association between coronary artery disease (CAD) patients developing a cardiac event and 8-OHdG concentrations. In conclusion, high levels of 8-OHdG in blood and urine are associated with atherosclerosis and heart failure, but further large prospective studies are needed to investigate 8-OHdG as a predictor for cardiovascular diseases.

PubMed Disclaimer

References

    1. Eur J Clin Invest. 2011 Jul;41(7):759-66 - PubMed
    1. Lab Invest. 1997 Mar;76(3):365-74 - PubMed
    1. Am J Cardiol. 2005 Feb 15;95(4):514-7 - PubMed
    1. Carcinogenesis. 2000 May;21(5):1017-22 - PubMed
    1. Circ Res. 1999 Oct 15;85(8):753-66 - PubMed

Publication types

MeSH terms

LinkOut - more resources